Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Martek partners with Hain

This article was originally published in The Tan Sheet

Executive Summary

Martek will serve as the exclusive DHA and ARA supplier for all Hain Celestial infant formula products in the U.S., under a license and supply agreement announced Aug. 8. The companies also said they are discussing the potential expansion of their relationship into other food and beverage products. Martek's vegetarian source of omega-3 and omega-6 fatty acids will be included in Hain Celestial's infant formula Earth's Best at levels shown through research to optimize brain and eye development. Martek's blend of DHA and ARA is the only source of these fatty acid nutrients used in U.S. infant formula 1("The Tan Sheet" June 19, 2006, In Brief and 2"The Tan Sheet" Jan. 16, 2006, p. 12). Hain Celestial manufactures products under brands such as Rice Dream and WestSoy...
Advertisement

Related Content

Martek/General Mills
Martek Reaches Beyond Infant Formula To Grab Perinatal, Food Markets

Topics

Advertisement
UsernamePublicRestriction

Register

PS099654

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel